Answers are grounded in this paper and cite their sources.
Systematic review shows CDSS-DI alerts did not significantly improve patient outcomes, suggesting a need for better alert systems.
Objectives Drug interaction checking software is ubiquitous in clinical decision support systems (CDSS-DI) but patient relevance and accuracy are variable and the impact on patient outcomes is unproven. We compared the effectiveness of CDSS-DI with similar care without CDSS-DI. Materials and Methods We searched multiple bibliographic databases from 1990 to end-2024 for randomized trials (RCTs) or prospective cohort studies evaluating CDSS-DI at prescription, dispensing, or administration compared to a control group, and assessing clinical, process and burden outcomes. We used Cochrane Risk of Bias v2.0 and ROBINS-I to assess risk of bias and random effects modeling using meta 6.0 package in R for meta-analysis. Results Eight studies were included—7 RCTs (2 parallel and 5 cluster) and 1 prospective cohort study (total N = 43 413 patients). Mortality rates were similar between intervention (0.14%) and control (0.07%) groups (OR: 1.94 [95% CI: 0.88-4.29], P = .078). One study reported a minor, possibly irrelevant, 3-hour decrease in length of stay (P = .0021) in the intervention group. CDSS-DI alerts modestly influenced prescribing behavior (OR: 2.08 [95% CI: 1.01-4.27], P = .05), but did not significantly reduce the incidence of targeted adverse drug interactions (OR: 0.86 [95% CI: 0.56-1.34], P = .37). Discussion Surprisingly little high-quality research addresses the effect of CDSS-DI on patient or clinician outcomes. Current evidence continues to suggest no major benefit for patient-important outcomes. Given the potential for harms and important time burdens, CDSS-DI alerting needs improvement. Conclusion CDSS-DI alerts show no significant improvement in patient-important outcomes. Optimizing alert accuracy, clinical relevance, and patient-specific integration is essential to enhance their value in practice.
No takes yet. Share an insight, caveat, or question.
Holbrook et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: